ARD1A antibody

GeneTex

ARD1A antibody

9

WB: 1:500 - 1:2000. ICC/IF: 1:50 - 1:100. IHC-P: 1:50 - 1:200. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

Unconjugated

NAA10

N-alpha-acetyltransferase 10, NatA catalytic subunit

ARD1, ARD1A, ARD1P, DXS707, LZMS, MAA, MCOPS1, NATD, OGDNS, TE2, hARD1, N-alpha-acetyltransferase 10, ARD1 homolog A, N-acetyltransferase, N-acetyltransferase ARD1, human homolog of, N-terminal acetyltransferase complex ARD1 subunit homolog A, arrest defective protein 1, microphthalmia or anophthalmia and associated anomalies, natA catalytic subunit Naa10

Rabbit

IgG

N-alpha-acetyltransferase 10

N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes an N-terminal acetyltransferase that functions as the catalytic subunit of the major amino-terminal acetyltransferase A complex. Mutations in this gene are the cause of Ogden syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Jan 2012]

-20°C or -80°C,2°C to 8°C

12352203